Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Early Stage Lung Cancer (I and II) 1

Interventions

Cyclophosphamide 391Carboplatin 344Gemcitabine 332pembrolizumab 331Cisplatin 328Paclitaxel 298Radiotherapy 297Docetaxel 287Bevacizumab 253Rituximab 234Capecitabine 224Nivolumab 222Dexamethasone 206Fluorouracil 190fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 134Cetuximab 130fludarabine phosphate 129Bortezomib 129Lenalidomide 126Filgrastim 120Erlotinib Hydrochloride 120Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × leucoselect phytosome × Clear all
NCT04515004 2026-02-17

Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer

VA Office of Research and Development

Phase 2 Terminated
6 enrolled 3 charts
Thoracic

Early Stage Lung Cancer (I and II)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡